A study led by Xiujun Cai (Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine) screened the whole genome of hepatocellular carcinoma cells (HepG2) through CRISPR / cas9 system ...
Apr 19, 2022
0
2
Hepatocellular carcinoma (HCC) is the most primary liver cancer. It is one of the most common and deadly cancer worldwide, especially in East Asia. Advanced HCC patients expect a significantly low 5-year survival rate as ...
Apr 18, 2022
0
2
Scientists at UCL have significantly boosted the effectiveness of a therapeutic vaccine designed to control chronic hepatitis B (HBV) infection, after uncovering and thwarting 'the enemy within'.
Apr 13, 2022
0
62
Researchers are set to test a non-invasive treatment for inoperable early-stage liver cancer, with a new clinical trial to commence this year across Australia.
Feb 24, 2022
0
3
Hepatocellular carcinoma (HCC), the most common form of primary liver cancer, remains a deadly cancer with an incidence that has tripled in the United States since 1980. Individuals with HCC often present at an intermediate ...
Feb 22, 2022
0
2
One-fifth. Nearly 20% of cancers worldwide are caused by a virus.
Feb 2, 2022
0
6
Sonodynamic therapy uses ultrasound in combination with drugs to release harmful reactive oxygen species (ROS) at the site of a tumor. However, the treatment isn't very effective because cancer cells can activate antioxidant ...
Dec 8, 2021
0
66
There are still no established biomarkers to predict the success of immunotherapy in patients with liver cancer. In a multicentre study led by Matthias Pinter from the Division of Gastroenterology and Hepatology of the Medical ...
Nov 22, 2021
0
5
(HealthDay)—Elevated serum iron and transferrin saturation levels are significantly associated with an increased risk for developing liver cancer in patients with nonalcoholic fatty liver disease (NAFLD), according to a ...
Nov 16, 2021
0
2
People with liver cancer awaiting transplantation could benefit from non-invasive radiation treatments but are rarely given this therapy, according to a new analysis of U.S. national data. Findings will be presented today ...
Oct 25, 2021
0
7
